X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
research (7) 7
analysis (5) 5
health aspects (5) 5
antiviral agents (4) 4
care and treatment (4) 4
female (4) 4
humans (4) 4
infectious diseases (4) 4
male (4) 4
poster presentation (4) 4
adult (3) 3
aged (3) 3
comorbidity (3) 3
complications and side effects (3) 3
hepatitis (3) 3
hepatitis c (3) 3
hiv infection (3) 3
index medicus (3) 3
medical research (3) 3
medicine, experimental (3) 3
middle aged (3) 3
risk factors (3) 3
antiviral agents - adverse effects (2) 2
antiviral agents - therapeutic use (2) 2
biological response modifiers (2) 2
chronic kidney failure (2) 2
cohort studies (2) 2
daa (2) 2
diagnosis (2) 2
drug therapy (2) 2
drug therapy, combination (2) 2
gastroenterology (2) 2
hepacivirus - drug effects (2) 2
hepacivirus - genetics (2) 2
hepatitis c virus (2) 2
hepatitis c, chronic - drug therapy (2) 2
hiv (2) 2
interferon (2) 2
meeting abstracts (2) 2
oral presentation (2) 2
patients (2) 2
ribavirin (2) 2
usage (2) 2
virus diseases (2) 2
abridged index medicus (1) 1
absorptiometry, photon (1) 1
abt-450/r-ombitasvir (1) 1
administration, oral (1) 1
adolescent (1) 1
adult; aged; anemia; antiviral agents; asthenia; cohort studies; dose-response relationship, drug; drug therapy, combination; female; hepacivirus; hepatitis c, chronic; host-pathogen interactions; humans; interferon-alpha; male; middle aged; neutropenia; outcome assessment; polyethylene glycols; proportional hazards models; rna, viral; recombinant proteins; ribavirin; withholding treatment; medicine (1) 1
adverse and side effects (1) 1
aged, 80 and over (1) 1
anemia - chemically induced (1) 1
anilides - administration & dosage (1) 1
anilides - adverse effects (1) 1
anilides - therapeutic use (1) 1
antibiotic resistance (1) 1
antigens (1) 1
antiretroviral drugs (1) 1
antiviral agents - administration & dosage (1) 1
antiviral therapy (1) 1
asthenia - chemically induced (1) 1
bacterial infections (1) 1
biology and life sciences (1) 1
body mass (1) 1
body mass index (1) 1
body size (1) 1
bone mineral density (1) 1
bone-mineral density (1) 1
bones (1) 1
burden (1) 1
carbamates - administration & dosage (1) 1
carbamates - adverse effects (1) 1
carbamates - therapeutic use (1) 1
carcinoma, squamous cell - classification (1) 1
carcinoma, squamous cell - pathology (1) 1
carrier proteins - antagonists & inhibitors (1) 1
cd4 lymphocyte count (1) 1
cerebral spinal fluid (1) 1
child (1) 1
child, preschool (1) 1
children & youth (1) 1
chronic hcv (1) 1
chronic infection (1) 1
chronic kidney disease (1) 1
chronic kidney-disease (1) 1
clinical medicine (1) 1
clostridium difficile infection (1) 1
cross-sectional studies (1) 1
cytokines (1) 1
daclatasvir (1) 1
dasabuvir (1) 1
ddi (1) 1
density (1) 1
developmental biology (1) 1
diagnostic delay (1) 1
digestive system diseases (1) 1
direct-acting antivirals (1) 1
distribution (1) 1
dose-response relationship, drug (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 2013, Volume 13, Issue Suppl 1, pp. P53 - P53
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2013, Volume 13, Issue S1, pp. P29 - P29
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2013, Volume 13, Issue S1, pp. O12 - O12
Journal Article
Farmacia, ISSN 0014-8237, 2017, Volume 65, Issue 1, pp. 136 - 141
The treatment of chronic HCV infection has been redesigned with the advent of direct-acting antivirals which substantially increase the rate of sustained... 
DDI | Paritaprevir | Interactions | Hepatitis C | DAA | hepatitis C | PHARMACOLOGY & PHARMACY | paritaprevir | interactions | PREDICTION
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 4, pp. 971 - 980.e1
Background & Aims Interferon-free treatment options are rapidly evolving for patients with chronic hepatitis C virus (HCV) genotype 1b (GT1b) infection with... 
Gastroenterology and Hepatology | Direct-Acting Antivirals | Interferon-Free/Ribavirin-Free | HCV Genotype 1b | ABT-450/R-OMBITASVIR | CHRONIC HCV | RANDOMIZED-TRIAL | RIBAVIRIN | PEGINTERFERON ALPHA-2A | PLUS SOFOSBUVIR | DASABUVIR | TREATMENT-EXPERIENCED PATIENTS | DACLATASVIR | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Recurrence | Anilides - therapeutic use | United States | Anilides - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Carbamates - administration & dosage | Hepatitis C, Chronic - complications | Enzyme Inhibitors - administration & dosage | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Female | Drug Therapy, Combination | Enzyme Inhibitors - adverse effects | Hepacivirus - drug effects | Liver Cirrhosis - drug therapy | Liver Cirrhosis - diagnosis | Ritonavir - administration & dosage | Administration, Oral | Antiviral Agents - therapeutic use | Europe | Carrier Proteins - antagonists & inhibitors | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Enzyme Inhibitors - therapeutic use | Remission Induction | Macrocyclic Compounds - therapeutic use | Hepacivirus - enzymology | Liver Cirrhosis - virology | Anilides - administration & dosage | Antiviral Agents - adverse effects | Carbamates - adverse effects | Aged | Macrocyclic Compounds - administration & dosage | Carbamates - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Virus diseases | Medical research | Proteases | Ritonavir | Analysis | Liver | Medicine, Experimental | Biological response modifiers | Hepatitis C virus | Health aspects | Gangliosides | Liver cirrhosis
Journal Article
GERMS, ISSN 2248-2997, 2013, Volume 3, Issue 2, pp. 49 - 51
Asymptomatic carriage of Staphylococcus aureus is common, particularly in the anterior part of the nasal cavity. Apart from nasal and nasopharyngeal carriage,... 
Nasal carriage | Staphylococcus aureus | Antibiotic resistance | MRSA | Host-bacteria relationships | Physiological aspects | Research | Nasal mucosa | Distribution | Staphylococcus infections | Nose | Children & youth
Journal Article
Revista Romana de Medicina de Laborator, ISSN 1841-6624, 10/2017, Volume 25, Issue 4, pp. 355 - 363
Introduction. The past years have revolutionized the treatment of hepatitis C virus (HCV) infection, with high rates of sustained virologic response (SVR).... 
liver fibrosis | HCV | DAA | SVR | prognostic laboratory markers | Liver fibrosis | Prognostic laboratory markers | MEDICINE, RESEARCH & EXPERIMENTAL | VIRUS-INFECTION | MANAGEMENT
Journal Article
by Niculae, Cristian-Mihail and Manea, Eliza and Jipa, Raluca and Merisor, Simona and Moroti, Ruxandra and Benea, Serban and Hristea, Adriana and Neguț, Alina Cristina and Săndulescu, Oana and Streinu-Cercel, Anca and Mărculescu, Dana and Andrei, Magdalena Lorena and Ilie, Veronica and Popa, Marcela and Bleotu, Coralia and Chifiriuc, Carmen and Popa, Mircea Ioan and Streinu-Cercel, Adrian and Orfanu, Alina and Popescu, Cristina and Leuștean, Anca and Catană, Remulus and Negru, Anca and Badea, Alexandra and Orfanu, Radu and Tilișcan, Cătălin and Aramă, Victoria and Aramă, Ştefan Sorin and Vișan, Constanța-Angelica and Drăgănescu, Anca-Cristina and Bilașco, Anuța and Kouris, Camelia and Merișescu, Mădălina and Vasile, Magdalena and Slavu, Diana-Maria and Vintilă, Sabina and Osman, Endis and Oprea, Alina and Sandu, Sabina and Luminos, Monica and Leuştean, Anca and Popescu, Gabriel Adrian and Stanculete, Ramona Georgiana and Enoiu, Ana Vaduva and Marinescu, Adelina Raluca and Lazureanu, Voichita and Marinescu, Adelina-Raluca and Crișan, Alexandru and Lăzureanu, Voichița and Musta, Virgil and Nicolescu, Narcisa and Laza, Ruxandra and Negru, Anca-Ruxandra and Munteanu, Daniela-Ioana and Mihăilescu, Raluca and Dorobăț, Olga and Rafila, Alexandru and Căpraru, Emilia and Niculescu, Marius and Marinescu, Rodica and Lupescu, Olivera and Predescu, Vlad and Tălăpan, Daniela and Popescu, Ramona Ștefania and Bradu, Luminița and Florea, Dragoș and Leca, Daniela Anicuta and Bunea, Elena and Teodor, Andra and Miftode, Egidia and Jugulete, Gheorghiță and Dobrotă, Anamaria and Ilie, Adina and Preoțescu, Liliana Lucia and Irimescu, Nicoleta and Panait, Irina and Niculae, Cristian and Gavriliu, Liana Cătălina and Benea, Otilia Elisabeta and Benea, Șerban and Popoiu, Mona and Dragonu, Livia and Cupşa, Augustin and Diaconescu, Iulian and Niculescu, Irina and Giubelan, Lucian and Dumitrescu, Florentina and Stoian, Andreea Cristina and Guţă, Camelia and Puiu, Simona and Irina, Bunescu and Vallée, Marilyse and Huletsky, Ann and Boudreau, Dominique K and Bérubé, Ève and Giroux, Richard and Longtin, Jean and Longtin, Yves and Bergeron, Michel G and Roșculeț, Cleo Nicoleta and ...
BMC Infectious Diseases, ISSN 1471-2334, 11/2016, Volume 16, Issue S4, pp. 31 - 76
Journal Article
by Cristian-Mihail Niculae and Eliza Manea and Raluca Jipa and Simona Merisor and Ruxandra Moroti and Serban Benea and Adriana Hristea and Alina Cristina Neguț and Oana Săndulescu and Anca Streinu-Cercel and Dana Mărculescu and Magdalena Lorena Andrei and Veronica Ilie and Marcela Popa and Coralia Bleotu and Carmen Chifiriuc and Mircea Ioan Popa and Adrian Streinu-Cercel and Alina Orfanu and Cristina Popescu and Anca Leuștean and Remulus Catană and Anca Negru and Alexandra Badea and Radu Orfanu and Cătălin Tilișcan and Victoria Aramă and Ştefan Sorin Aramă and Constanța-Angelica Vișan and Anca-Cristina Drăgănescu and Anuța Bilașco and Camelia Kouris and Mădălina Merișescu and Magdalena Vasile and Diana-Maria Slavu and Sabina Vintilă and Endis Osman and Alina Oprea and Sabina Sandu and Monica Luminos and Alina Orfanu and Victoria Aramă and Ştefan Sorin Aramă and Anca Leuştean and Remulus Catană and Anca Negru and Gabriel Adrian Popescu and Cristina Popescu and Ramona Georgiana Stanculete and Ana Vaduva Enoiu and Adelina Raluca Marinescu and Voichita Lazureanu and Adelina-Raluca Marinescu and Alexandru Crișan and Voichița Lăzureanu and Virgil Musta and Narcisa Nicolescu and Ruxandra Laza and Anca-Ruxandra Negru and Daniela-Ioana Munteanu and Raluca Mihăilescu and Remulus Catană and Olga Dorobăț and Alexandru Rafila and Emilia Căpraru and Marius Niculescu and Rodica Marinescu and Olivera Lupescu and Vlad Predescu and Adrian Streinu-Cercel and Victoria Aramă and Daniela Tălăpan and Ramona Ștefania Popescu and Luminița Bradu and Dragoș Florea and Adrian Streinu-Cercel and Daniela Anicuta Leca and Elena Bunea and Andra Teodor and Egidia Miftode and Mădălina Merișescu and Gheorghiță Jugulete and Adrian Streinu-Cercel and Dragoș Florea and Monica Luminos and Ramona Ștefania Popescu and Anamaria Dobrotă and Adina Ilie and Liliana Lucia Preoțescu and Adriana Hristea and Raluca Jipa and Nicoleta Irimescu and Irina Panait and Eliza Manea and Simona Merisor and Cristian Niculae and Daniela Tălăpan and Liana Cătălina Gavriliu and Otilia Elisabeta Benea and Șerban Benea and ...
BMC Infectious Diseases, 11/2016, Volume 16, Issue S4, pp. 31 - 76
Table of contents A1 The outcome of patients with recurrent versus non-recurrent pneumococcal meningitis in a tertiary health-care hospital in Bucharest... 
Respiratory Syncytial Virus | Clostridium Difficile Infection | Progressive Multifocal Leukoencephalopathy | Cerebral Spinal Fluid | Fecal Microbiota Transplantation
Journal Article
GERMS, ISSN 2248-2997, 2012, Volume 2, Issue 1, pp. 18 - 22
The role of specific antiviral treatment in severe acute hepatitis B has been subject to debate during the past few years. We present clinical findings in a... 
Severe acute hepatitis B | Antiviral therapy | Entecavir | Antiviral agents | Diagnosis | Research | Drug therapy | Health aspects | Hepatitis B | Antigens | Hepatitis | Enzymes | Antiretroviral drugs | Immunoglobulins | Cytokines | Patients
Journal Article
Journal of Contemporary Clinical Practice, ISSN 2457-7200, 03/2016, Volume 2, Issue 1, pp. 25 - 30
Background Bone mineral density (BMD) is known to fluctuate with age, hormonal profile, or presence of comorbidities. Bone evaluation in HIV positive patients... 
Infection | Medical research | Osteoporosis | Chronic kidney failure | Comorbidity | Analysis | Medicine, Experimental | Bones | HIV (Viruses) | HIV infection | Density | Prevalence studies (Epidemiology)
Journal Article
Journal of Contemporary Clinical Practice, ISSN 2457-7200, 09/2016, Volume 2, Issue 2, pp. 59 - 68
Journal Article
Journal of Contemporary Clinical Practice, ISSN 2457-7200, 09/2016, Volume 2, Issue 2, p. 59
Background Peginterferon and ribavirin treatment has been the standard of care for chronic hepatitis C for a long time, but it has started to be replaced by... 
Medical research | Patient education | Analysis | Medicine, Experimental | Interferon | Research | Biological response modifiers | Hepatitis C | Drug therapy | Health aspects | Patient compliance
Journal Article
by Foster, Graham R and Coppola, Carmine and Derbala, Moutaz and Ferenci, Peter and Orlandini, Alessandra and Reddy, K. Rajender and Tallarico, Ludovico and Shiffman, Mitchell L and Ahlers, Silke and Bakalos, Georgios and Hassanein, Tarek and Basho, Jovan and Shabanaj, Gentian and Harxhi, Arjan and Debzi, Nabil and Afredj, Nawel and Guessab, Nawal and Mahindad, Nadir and Mahiou, Hassene and Aissaoui, Magda and Al Qameesh, Jihad and Al Ghandoor, Zuhal and Assene, Collins and Bastens, Boris and Brixko, Christian and Cool, Mike and De Galocsy, Chantal and Delwaide, Jean and George, Christophe and Laukens, Pierre and Lefebvre, Veronique and Mulkay, Jean-Pierre and Nevens, Frederik and Servais, Benoit and Van Vlierberghe, Hans and Horsmans, Yves and Henrion, Jean and Sprengers, Dirk and Michielsen, Peter and Bourgeois, Stefan and Lasser, Luc and Langlet, Philippe and Robaeys, Geert and Martinet, Jean-Paul and Warzee, Philippe and Hoste, Paul and Reynaert, Hendrik and Juriens, Irène and Decaestecker, Jochen and Van Der Meersch, Filip and Janssens, Filip and Ahmetagic, Sead and Verhaz, Antonija and Bevanda, Milenko and Calkic, Lejla and Ibrahimpasic, Nevzeta and Mesihovic, Rusmir and Mello, Carlos Eduardo and Ruiz, Fernando Jose and Junior, Elson Martins and Ferraz, Maria Lucia and Silva, Giovanni and Mendes, Claudio and Lyra, Andre and Silva, Mariliza Henrique and Gomide, Geisa and Fernandes, Julio Cesar and Pereira, Patricia and Correa, Maria Cassia and Teixeira, Rosangela and Yousry, Ayman and Hanno, Abdelfatah and Gabr, Mamdouh and Omar, Ashraf and Esmat, Gamal and Karatapanis, Stilianos and Nikolopoulou, Vassiliki and Giannoulis, Grigoris and Manolakopoulos, Spilios and Elefsiniotis, Ioannis and Drakoulis, Christos and Dimitroulopoulos, Dimitrios and Kanatakis, Stilianos and Ketikoglou, Ioannis and Mimidis, Konstantinos and Evgenidis, Nikolaos and Akriviades, Euaggelos and Vafiadi-Zoubouli, Irini and Tsianos, Epameinondas and Mela, Maria and Orfanou, Eleni and Mousoulis, Georgios and Karagiannis, Ioannis and Manesis, Emmanuel and Varga, Marta and Nemesánszky, Elemér and Fried, Katalin and Schuller, János and Szalay, Ferenc and Lengyel, Gabriella and ... and GUARD-C Study Grp and GUARD-C Study Group
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, p. e0151703
Background Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains... 
MULTIDISCIPLINARY SCIENCES | Outcome Assessment (Health Care) - methods | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Host-Pathogen Interactions - drug effects | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Dose-Response Relationship, Drug | RNA, Viral - genetics | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Neutropenia - chemically induced | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Proportional Hazards Models | Anemia - chemically induced | Hepatitis C, Chronic - drug therapy | Withholding Treatment | Asthenia - chemically induced | Outcome Assessment (Health Care) - statistics & numerical data | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Cohort Studies | Influence | Care and treatment | Interferon | Research | Hepatitis C | Analysis | Laboratories | Medical services | Chronic infection | Viruses | Infections | Ribavirin | Impact analysis | Hepatitis | Ethics | Body mass index | Genotype & phenotype | Hepatology | Gastroenterology | Safety | Genotypes | Antiviral agents | Hematology | Enrollments | Lung diseases | Ribonucleic acid--RNA | Patients | Body mass | Body size | Clinical medicine | Hepatitis C virus | RNA | Ribonucleic acid
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.